Irrelevant to patient gender or age, IARS2 transcription level was significantly higher in pancreatic cancer at tumor grade 3–4 compared with grade 1–2 (P = 0.02; Fig. 1E; Fig. S1). This evidence concerns the gene IARS2 and pancreatic neoplasm.